|
METASTATIC COLORECTAL
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis from Colon
Cancer with Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin chemotherapy,
and anti-Angiogenic Therapy
PI: Robert Martin, MD, PhD
RC: Tiffany Metzger, (502) 629-3383
tiffany.metzger@louisville.edu
Pager 464-0242
MELANOMA
Transcatheter arterial chemoembolization with doxorubicin-loaded LC beads in the treatment of liver-dominant metastases in patients with stage IV metastatic melanoma: A multi-center, non-randomized, feasibility trial
PI: Robert Martin, MD, PhD
RC: Tiffany Metzger, (502) 629-3383
tiffany.metzger@louisville.edu
Pager 464-0242
For more details, watch our stage 4 melanoma to the liver clinical trial video
A Phase III Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma.
PI: Kelly M. McMasters, MD, PhD
RC: Debby Hulsewede, CCRC, CCRP (502) 629-3308
Deborah.hulsewede@nortonhealthcare.org
Pager 299-1301
An Open, Single-Arm Study to Assess the Clinical Activity of recMAGE-A3 + AS15 in Patients with Unresectable, MAGE-A3 Positive Metastatic Cutaneous Melanoma
PI: Kelly M. McMasters, MD, PhD
RC: Debby Hulsewede, CCRC, CCRP (502) 629-3308
Deborah.hulsewede@nortonhealthcare.org
Pager 299-1301
A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 ASCI as Adjuvant Therapy in Patients with Mage-A3-Positive Resected Stage III Melanoma
PI: Kelly M. McMasters, MD, PhD
RC: Debby Hulsewede, CCRC, CCRP
(502) 629-3308
Deborah.hulsewede@nortonhealthcare.org
Pager 299-1301
PANCREAS
A Phase II Study of Low Dose Hyperacute®-Pancreatic Cancer Vaccine in Subjects with Surgically Resected Pancreatic Cancer
PI: Charles Scoggins, MD, MBA
RC: Debby Hulsewede, CCRC, CCRP (502) 629-3308
Deborah.hulsewede@nortonhealthcare.org
Pager 299-1301
A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Carcinoma
PI: Robert Martin, MD, PhD
RC: Susan Ellis, RN, (502) 629-3384
mailto:susan.ellis@louisville.edu
pager 478-1235
Clinical Evaluation of Neaodjuvant Gemcitabine, Docetaxel, and Capecitabine with Concurrent Radiation for Patients with Potentially Resectable Pancreatic Carcinoma
PI: Robert Martin, MD, PhD
RC: Susan Ellis, RN, (502) 629-3384
mailto:susan.ellis@louisville.edu
pager 478-1235
ESOPHAGEAL
Clinical Evaluation of Polyflex® Stenting in Esophageal Cancer Patients undergoing Chemotherapy and/or Radiation Therapy
PI: Robert Martin, MD, PhD
RC: Susan Ellis, RN, (502) 629-3384
mailto:susan.ellis@louisville.edu
pager 478-1235
A Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients with Locall Advanced Adenocarcinoma of the Distal Esophagus
PI: Robert Martin, MD, PhD
RC: Susan Ellis, RN, (502) 629-3384
mailto:susan.ellis@louisville.edu
pager 478-1235
HEPATOCELLULAR
A Phase III Randomized, Double-Blind, Placebo-Controlled Study of Sorafenib as Adjuvant Treatment for Hepatocellular Carcinoma after Surgical Resection or Local Ablation
PI: Robert Martin, MD, PhD
RC: Susan Ellis, RN, (502) 629-3384
mailto:susan.ellis@louisville.edu
pager 478-1235
HEAD AND NECK
A Randomized Phase II Trial of Chemoradiotherapy versus Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck
PI: William Spanos, MD
RC: Stacy Baum, RN,
(502) 562-3429
|
